Replies to post #48887 on Intellicell Biosciences Inc (fka SVFC)

[gempicker]

Yes.

But years from now. There is a ton of revenue and clinical build out necessary, even with the leading stem cell technology.

Near term targets is a price recovery back into the 3-5 cent range, with larger partnerships and more exposure sending this into the several hundred million mrkt cap range later this year, so maybe .10-.20 this year.

Those are reasonable targets for 2014.